Evidence map›Paper›PMID 25089237›Full record

ArticleNatural products and bioprospecting2014

Effects of Traditional Chinese Medicinal Plants on Anti-insulin Resistance Bioactivity of DXMS-Induced Insulin Resistant HepG2 Cells.

Jun-Zeng Ma, Li-Xin Yang, Xiao-Ling Shen, Ji-Huan Qin, Li-Lan Deng, Selena Ahmed, Hong-Xi Xu, Da-Yuan Xue, Jiang-Xia Ye, Gang Xu

Open access · diamondAbstract read
In one paragraph

Article in Natural products and bioprospecting, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. The genusIranian journal of basic medical sciences · 2019
    Review
  5. Resveratrol affects hepatic gluconeogenesis via histone deacetylase 4.Diabetes, metabolic syndrome and obesity : targets and therapy · 2019
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Jun-Zeng MaState Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201 People's Republic of China.
Li-Xin YangState Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201 People's Republic of China ; College of Life and Environmental Science, Minzu University of China, 27 ZhongGuanCun South Avenue, Beijing, 100086 China.
Xiao-Ling ShenLaboratory of Chinese Herbal Drug Discovery, Tropical Medicine Institute, Guangzhou University of Chinese Medicine, Guangzhou, 510405 People's Republic of China.
Ji-Huan QinLaboratory of Chinese Herbal Drug Discovery, Tropical Medicine Institute, Guangzhou University of Chinese Medicine, Guangzhou, 510405 People's Republic of China.
Li-Lan DengSouthwest Forestry University, Kunming, 650224 People's Republic of China.
Selena AhmedCollege of Life and Environmental Science, Minzu University of China, 27 ZhongGuanCun South Avenue, Beijing, 100086 China ; Sustainable Food and Bioenergy Systems Program, Department of Health and Human Development, Montana State University, Bozeman, MT 59717 USA.
Hong-Xi XuShanghai University of Traditional Chinese Medicine, Shanghai, 201203 People's Republic of China.
Da-Yuan XueCollege of Life and Environmental Science, Minzu University of China, 27 ZhongGuanCun South Avenue, Beijing, 100086 China.
Jiang-Xia YeSouthwest Forestry University, Kunming, 650224 People's Republic of China.
Gang XuState Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201 People's Republic of China.
Guangzhou University of Chinese Medicine · CNKunming Institute of Botany · CNSouthwest Forestry University · CNChinese Academy of Sciences · CNMinzu University of China · CNMontana State University · USShanghai University of Traditional Chinese Medicine · CN

Funding

Training in Education and Critical Research SkillsK12GM074869 · NIGMS · TUFTS UNIVERSITY BOSTON · PI MOORE, CLAIRE L · 2006 to 2017
$8.5M
NIGMS NIH HHS K12 GM074869
6 · The paper itself

Abstract

abstractMedicinal plants have a long history of use in China to treat diabetic symptoms. Ancient Chinese medical manuscripts and ethnobotanical surveys document plant remedies that continue to be actively used in China for the treatment of diabetic symptoms. Based on a systematic ancient Chinese medical manuscripts review in combination with ethnobotanical survey, 16 medicinal plants for the traditional treatment of diabetic symptoms were identified for the evaluation of anti-insulin resistance bioactivity. The biological activity of 16 medicinal plants was tested on dexamethasone (DXMS)-induced insulin resistant HepG2 cells. The result shows that 11 of the 16 medicinal plants enhanced glucose uptake of DXMS-induced insulin resistant HepG2 cells, thereby demonstrating their ability to increase insulin sensitivity, other five medicinal plants including Astragalus membranaceus were found ineffective. The study shows that ancient Chinese medical manuscripts and ethnobotanical surveys on plants for the prevention and treatment of diabetic symptoms provide a promising knowledge base for drug discovery to mitigate the global diabetes epidemic.

Indexed as

Anti-insulin resistance bioactivityDiabetesDXMS-induced insulin resistant HepG2 cellsTraditional medicinal plants

Identifiers

PMID25089237
PMCPMC4111871
OpenAlexW2000696158

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.